Close
Novotech
Jabsco PureFlo 21 Single Use

Xcellerex launches new bag-type XDR-10 single-use bioreactor

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

How Lead Selection Impacts CMC Strategy in Drug Development

The molecule you choose to advance into development doesn't just define your science it defines your entire Chemistry, Manufacturing, and Controls roadmap. This article unpacks how early lead selection decisions ripple through CMC planning, regulatory timelines, and ultimately, your path to the clinic.

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...
- Advertisement -

Xcellerex, a provider of manufacturing technologies, has launched new XDR-10 single-use bioreactor.

The new system, which is available in single-, twin-, triplet-, and quad-vessel configurations, is flexible to handle volumes from 4l to 10l.

The XDR-10 is an integral component of the Xcellerex FlexFactory modular biomanufacturing platform that leverages single-use technology and advanced process automation.

The new system features a low shear, high input-power impeller with optimized position which maximizes volume range and turndown ratio.

The XDR-10 can function as a production vessel in its own right, or become a scale-down tool or satellite platform for larger projects to be continued in larger bioreactors, according to the company.

The flexible platform enables biomanufacturers to speed up deployment of new manufacturing capacity with reduced capital costs and lowered risk.

Latest stories

Related stories

How Lead Selection Impacts CMC Strategy in Drug Development

The molecule you choose to advance into development doesn't just define your science it defines your entire Chemistry, Manufacturing, and Controls roadmap. This article unpacks how early lead selection decisions ripple through CMC planning, regulatory timelines, and ultimately, your path to the clinic.

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »